NCT02687789 - Safety, Tolerability and Efficacy of Vaginal Suppository WO3191 in the Post-treatment of Bacterial Vaginosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

September 30, 2015

Conditions

Vaginosis, Bacterial

Interventions

OTHER

Medical Device: WO3191

application of vaginal suppository WO3191: 2 days per week (with a treatment-free interval of three days or two days, respectively; e.g. Monday and Friday)

OTHER

Medical Device: Vagisan® Lactic Acid

application of Vagisan® Lactic Acid: 2 days per week (with a treatment-free interval of three days or two days, respectively; e.g. Monday and Friday)

Trial Locations (13)

Unknown

Dr. Gerick, Aachen

Dr. Hofmann, Betzdorf

Dr. de Brabandt, Bielefeld

Dr. Werner Göttker-Schnetmann, Frankfurt

Dr. Deininger, Munich

Dr. Kränzlin, Munich

Dr. Kästner, Munich

Dr. Kühne, Munich

Bianca Moll-Bosch, Siegen

Dr. Susanne Feidicker, Steinhagen

Thomas Riepen, Weilburg

Dr. Waldschütz, Wuppertal

Prof. Mendling, Wuppertal